PDF herunterladen
Semin Liver Dis 2006; 26(2): 104-115
DOI: 10.1055/s-2006-939755
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Immunopathogenesis: Role of Innate and Adaptive Immune Responses

Kumar Visvanathan1 , 3 , Sharon R. Lewin2 , 3
  • 1Department of Infectious Diseases, Monash Medical Centre, Clayton, Victoria, Australia
  • 2Infectious Diseases Unit, Alfred Hospital, Prahran, Victoria, Australia
  • 3Department of Medicine, Monash University, Melbourne, Victoria, Australia
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
03. Mai 2006 (online)

    Lizenzen und Reprints

ABSTRACT

Hepatitis B virus (HBV) infection in immunocompetent adults usually results in a self-limited, transient liver disease and viral clearance, with only a small percentage (5 to 10%) developing chronic hepatitis associated with viral persistence. In contrast, when neonates are infected, more than 90% become persistently infected, suffering differing degrees of chronic liver disease. Activation of immunity plays a central role in host-virus interactions, greatly influencing viral replication and the clinical outcome of infection. Although all of the specific mechanisms and consequences of this interaction have not been elucidated, the purpose of this article is to describe the basic arms of the immune system as they interact with the HBV and describe the present state of knowledge in this area. These arms may be divided broadly into innate and specific immune responses, and they have different roles and responses in acute and chronic infection.

KEYWORDS

Immunoevasion - toll receptors - noncytolytic clearance - antiviral cytokines - interferons - T-cell responses

REFERENCES

  • 1 Dandri M, Lutgehetmann M, Volz T, Petersen J. Small animal models for studying hepatitis B virus replication and pathogenesis.  Semin Liver Dis. 2006;  26 181-191
    Thieme ConnectPubMedSuche in Google Scholar
  • 2 Zoulim F. In vitro models for studying hepatitis B virus drug resistance.  Semin Liver Dis. 2006;  26 171-180
    Thieme ConnectPubMedSuche in Google Scholar
  • 3 Murray J M, Wieland S F, Purcell R H, Chisari F V. Dynamics of hepatitis B virus clearance in chimpanzees.  Proc Natl Acad Sci USA. 2005;  102 17780-17785
    CrossrefPubMedSuche in Google Scholar
  • 4 Guidotti L G, Rochford R, Chung J, Shapiro M, Purcell R, Chisari F V. Viral clearance without destruction of infected cells during acute HBV infection.  Science. 1999;  284 825-829
    CrossrefPubMedSuche in Google Scholar
  • 5 Webster G J, Reignat S, Maini M K et al.. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.  Hepatology. 2000;  32 1117-1124
    CrossrefPubMedSuche in Google Scholar
  • 6 Tang T J, Kwekkeboom J, Laman J D et al.. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection.  J Viral Hepat. 2003;  10 159-167
    CrossrefPubMedSuche in Google Scholar
  • 7 Lascar R M, Lopes A R, Gilson R J et al.. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection.  J Infect Dis. 2005;  191 1169-1179
    CrossrefPubMedSuche in Google Scholar
  • 8 Hoshino K, Takeuchi O, Kawai T et al.. Cutting edge-toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.  J Immunol. 1999;  162 3749-3752
    PubMedSuche in Google Scholar
  • 9 Nattermann J, Du X, Wei Y, Shevchenko D, Beutler B. Endotoxin-mimetic effect of antibodies against toll-like receptor 4.  J Endotoxin Res. 2000;  6 257-264
    CrossrefPubMedSuche in Google Scholar
  • 10 Muzio M, Bosisio D, Polentarutti N et al.. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells.  J Immunol. 2000;  164 5998-6004
    PubMedSuche in Google Scholar
  • 11 Akira S, Sato S. Toll-like receptors and their signaling mechanisms.  Scand J Infect Dis. 2003;  35 555-562
    PubMedSuche in Google Scholar
  • 12 Beutler B, Hoebe K, Du X, Ulevitch R J. How we detect microbes and respond to them: the Toll-like receptors and their transducers.  J Leukoc Biol. 2003;  74 479-485
    CrossrefPubMedSuche in Google Scholar
  • 13 Haynes L M, Moore D D, Kurt-Jones E A, Finberg R W, Anderson L J, Tripp R A. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus.  J Virol. 2001;  75 10730-10737
    CrossrefPubMedSuche in Google Scholar
  • 14 Rassa J C, Meyers J L, Zhang Y, Kudaravalli R, Ross S R. Murine retroviruses activate B cells via interaction with toll-like receptor 4.  Proc Natl Acad Sci USA. 2002;  99 2281-2286
    CrossrefPubMedSuche in Google Scholar
  • 15 Katze M G, He Y, Gale Jr M. Viruses and interferon: a fight for supremacy.  Nat Rev Immunol. 2002;  2 675-687
    CrossrefPubMedSuche in Google Scholar
  • 16 Wieland S F, Guidotti L G, Chisari F V. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.  J Virol. 2000;  74 4165-4173
    CrossrefPubMedSuche in Google Scholar
  • 17 Kimura K, Kakimi K, Wieland S, Guidotti L G, Chisari F V. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice.  J Immunol. 2002;  169 5188-5195
    PubMedSuche in Google Scholar
  • 18 Liu S, Khemlani L S, Shapiro R A et al.. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia.  Infect Immun. 1998;  66 5089-5098
    PubMedSuche in Google Scholar
  • 19 Liu S, Gallo D J, Green A M et al.. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide.  Infect Immun. 2002;  70 3433-3442
    CrossrefPubMedSuche in Google Scholar
  • 20 Herkel J, Jagemann B, Wiegard C et al.. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes.  Hepatology. 2003;  37 1079-1085
    CrossrefPubMedSuche in Google Scholar
  • 21 Isogawa M, Robek M D, Furuichi Y, Chisari F V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.  J Virol. 2005;  79 7269-7272
    CrossrefPubMedSuche in Google Scholar
  • 22 Wieland S F, Chisari F V. Stealth and cunning: hepatitis B and hepatitis C viruses.  J Virol. 2005;  79 9369-9380
    CrossrefPubMedSuche in Google Scholar
  • 23 Duan X Z, Wang M, Li H W, Zhuang H, Xu D, Wang F S. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans.  J Clin Immunol. 2004;  24 637-646
    CrossrefPubMedSuche in Google Scholar
  • 24 Alexopoulou L, Holt A C, Medzhitov R, Flavell R A. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3.  Nature. 2001;  413 732-738
    CrossrefPubMedSuche in Google Scholar
  • 25 Sprengers D, Molen R G, Kusters J G et al.. Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis.  J Viral Hepat. 2005;  12 507-512
    CrossrefPubMedSuche in Google Scholar
  • 26 Chen Y, Wei H, Sun R, Tian Z. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.  Int Immunopharmacol. 2005;  5 1839-1852
    CrossrefPubMedSuche in Google Scholar
  • 27 Kakimi K, Guidotti L G, Koezuka Y, Chisari F V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo.  J Exp Med. 2000;  192 921-930
    CrossrefPubMedSuche in Google Scholar
  • 28 Kimura K, Kakimi K, Wieland S, Guidotti L G, Chisari F V. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.  J Virol. 2002;  76 10702-10707
    CrossrefPubMedSuche in Google Scholar
  • 29 Pasquetto V, Guidotti L G, Kakimi K, Tsuji M, Chisari F V. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice.  J Exp Med. 2000;  192 529-536
    CrossrefPubMedSuche in Google Scholar
  • 30 Kakimi K, Lane T E, Chisari F V, Guidotti L G. Cutting edge: inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver.  J Immunol. 2001;  167 6701-6705
    PubMedSuche in Google Scholar
  • 31 Duan Z P, Zhao X Y, Huang D Z et al.. RANTES gene single nucleotide polymorphisms and expression in patients with chronic hepatitis B virus infection.  Chin Med J (Engl). 2005;  118 909-914
    PubMedSuche in Google Scholar
  • 32 Zhang P A, Li Y, Xu P, Wu J M. Polymorphisms of interleukin-1B and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B.  World J Gastroenterol. 2004;  10 1826-1829
    PubMedSuche in Google Scholar
  • 33 Godkin A, Davenport M, Hill A V. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness.  Hepatology. 2005;  41 1383-1390
    CrossrefPubMedSuche in Google Scholar
  • 34 Thimme R, Wieland S, Steiger C et al.. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.  J Virol. 2003;  77 68-76
    CrossrefPubMedSuche in Google Scholar
  • 35 Biermer M, Puro R, Schneider R J. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.  J Virol. 2003;  77 4033-4042
    CrossrefPubMedSuche in Google Scholar
  • 36 Guidotti L G, Ishikawa T, Hobbs M V, Matzke B, Schreiber R, Chisari F V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.  Immunity. 1996;  4 25-36
    CrossrefPubMedSuche in Google Scholar
  • 37 Feld J J, Heathcote E J. Hepatitis B e Antigen-positive chronic hepatitis B: natural history and treatment.  Semin Liver Dis. 2006;  26 116-129
    Thieme ConnectPubMedSuche in Google Scholar
  • 38 Thio C L, Carrington M, Marti D et al.. Class II HLA alleles and hepatitis B virus persistence in African Americans.  J Infect Dis. 1999;  179 1004-1006
    CrossrefPubMedSuche in Google Scholar
  • 39 Wu Y F, Wang L Y, Lee T D et al.. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan.  J Med Virol. 2004;  72 17-25
    CrossrefPubMedSuche in Google Scholar
  • 40 Thio C L, Mosbruger T, Astemborski J et al.. Mannose binding lectin genotypes influence recovery from hepatitis B virus infection.  J Virol. 2005;  79 9192-9196
    CrossrefPubMedSuche in Google Scholar
  • 41 Maini M K, Boni C, Lee C K et al.. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.  J Exp Med. 2000;  191 1269-1280
    CrossrefPubMedSuche in Google Scholar
  • 42 Webster G J, Reignat S, Brown D et al.. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy.  J Virol. 2004;  78 5707-5719
    CrossrefPubMedSuche in Google Scholar
  • 43 Rossol S, Marinos G, Carucci P, Singer M V, Williams R, Naoumov N V. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B.  J Clin Invest. 1997;  99 3025-3033
    PubMedSuche in Google Scholar
  • 44 Ferrari C, Penna A, Bertoletti A et al.. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.  J Immunol. 1990;  145 3442-3449
    PubMedSuche in Google Scholar
  • 45 Maini M K, Boni C, Ogg G S et al.. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.  Gastroenterology. 1999;  117 1386-1396
    PubMedSuche in Google Scholar
  • 46 Rehermann B, Fowler P, Sidney J et al.. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.  J Exp Med. 1995;  181 1047-1058
    CrossrefPubMedSuche in Google Scholar
  • 47 Matsumura S, Yamamoto K, Shimada N et al.. High frequency of circulating HBcAg-specific CD8 T cells in hepatitis B infection: a flow cytometric analysis.  Clin Exp Immunol. 2001;  124 435-444
    CrossrefPubMedSuche in Google Scholar
  • 48 Hyodo N, Nakamura I, Imawari M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection.  Clin Exp Immunol. 2004;  135 462-466
    CrossrefPubMedSuche in Google Scholar
  • 49 Penna A, Chisari F V, Bertoletti A et al.. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.  J Exp Med. 1991;  174 1565-1570
    CrossrefPubMedSuche in Google Scholar
  • 50 Mizukoshi E, Sidney J, Livingston B et al.. Cellular immune responses to the hepatitis B virus polymerase.  J Immunol. 2004;  173 5863-5871
    PubMedSuche in Google Scholar
  • 51 Chang J J, Wightman F, Bartholomeusz A et al.. Reduced HBV-specific CD4+ T-cell responses in HIV-1-HBV co-infected individuals receiving HBV-active antiretroviral therapy.  J Virol. 2005;  79 3038-3051
    CrossrefPubMedSuche in Google Scholar
  • 52 Boni C, Bertoletti A, Penna A et al.. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.  J Clin Invest. 1998;  102 968-975
    PubMedSuche in Google Scholar
  • 53 Malacarne F, Webster G J, Reignat S et al.. Tracking the source of the hepatitis B virus-specific CD8 T cells during lamivudine treatment.  J Infect Dis. 2003;  187 679-682
    CrossrefPubMedSuche in Google Scholar
  • 54 Tang T J, de Man R A, Kusters J G et al.. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.  J Med Virol. 2004;  72 215-222
    CrossrefPubMedSuche in Google Scholar
  • 55 Lai C L, Chien R N, Leung N W et al.. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.  N Engl J Med. 1998;  339 61-68
    CrossrefPubMedSuche in Google Scholar
  • 56 Leung N W, Lai C L, Chang T T et al.. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.  Hepatology. 2001;  33 1527-1532
    CrossrefPubMedSuche in Google Scholar
  • 57 Marinos G, Torre F, Chokshi S et al.. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.  Hepatology. 1995;  22 1040-1049
    CrossrefPubMedSuche in Google Scholar
  • 58 Tang T J, Kwekkeboom J, Mancham S et al.. Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection.  J Hepatol. 2005;  43 45-52
    CrossrefPubMedSuche in Google Scholar
  • 59 Lau G K, Piratvisuth T, Luo K X et al.. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.  N Engl J Med. 2005;  352 2682-2695
    CrossrefPubMedSuche in Google Scholar
  • 60 Flink H J, Sprengers D, Hansen B E et al.. Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {α}-2b therapy.  Gut. 2005;  54 1604-1609
    CrossrefPubMedSuche in Google Scholar
  • 61 Griffith T S, Brunner T, Fletcher S M, Green D R, Ferguson T A. Fas ligand-induced apoptosis as a mechanism of immune privilege.  Science. 1995;  270 1189-1192
    PubMedSuche in Google Scholar
  • 62 Limmer A, Ohl J, Kurts C et al.. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance.  Nat Med. 2000;  6 1348-1354
    CrossrefPubMedSuche in Google Scholar
  • 63 Beckebaum S, Cicinnati V, Zhang X et al.. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape.  Immunology. 2003;  109 487-495
    CrossrefPubMedSuche in Google Scholar
  • 64 van der Molen R G, Sprengers D, Binda R S et al.. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.  Hepatology. 2004;  40 738-746
    CrossrefPubMedSuche in Google Scholar
  • 65 Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator.  J Gastroenterol. 2001;  36 651-660
    CrossrefPubMedSuche in Google Scholar
  • 66 Zhou D X, Taraboulos A, Ou J H, Yen T S. Activation of class I major histocompatibility complex gene expression by hepatitis B virus.  J Virol. 1990;  64 4025-4028
    PubMedSuche in Google Scholar
  • 67 Milich D, Liang T J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.  Hepatology. 2003;  38 1075-1086
    CrossrefPubMedSuche in Google Scholar
  • 68 Milich D R, Wolf S F, Hughes J L, Jones J E. Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice.  Proc Natl Acad Sci USA. 1995;  92 6847-6851
    PubMedSuche in Google Scholar
  • 69 Bartholomeusz A, Locarnini S. Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype.  Hepatology. 2001;  34 432-435
    CrossrefPubMedSuche in Google Scholar
  • 70 Visvanathan K, Skinner N, Locarnini S, Williams R, Riordan S M. Impaired toll-like receptor expression in chronic hepatitis B.  Gut. 2003;  52 130
    CrossrefPubMedSuche in Google Scholar
  • 71 Ribeiro R M, Lo A, Perelson A S. Dynamics of hepatitis B virus infection.  Microbes Infect. 2002;  4 829-835
    CrossrefPubMedSuche in Google Scholar
  • 72 Tedder R S, Ijaz S, Gilbert N et al.. Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers.  J Med Virol. 2002;  68 505-512
    CrossrefPubMedSuche in Google Scholar
  • 73 Bonecchi R, Bianchi G, Bordignon P P et al.. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.  J Exp Med. 1998;  187 129-134
    CrossrefPubMedSuche in Google Scholar
  • 74 Friedman S L. Molecular regulation of hepatic fibrosis: an integrated cellular response to tissue injury.  J Biol Chem. 2000;  275 2247-2250
    CrossrefPubMedSuche in Google Scholar
  • 75 Lee J Y, Chae D W, Kim S M et al.. Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection.  J Viral Hepat. 2004;  11 130-135
    CrossrefPubMedSuche in Google Scholar
  • 76 Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores G J. Apoptotic body engulfment by a human stellate cell line is profibrogenic.  Lab Invest. 2003;  83 655-663
    CrossrefPubMedSuche in Google Scholar
  • 77 Akpolat N, Yahsi S, Godekmerdan A, Demirbag K, Yalniz M. Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B.  World J Gastroenterol. 2005;  11 3260-3263
    PubMedSuche in Google Scholar
  • 78 Akashi S, Shimazu R, Ogata H et al.. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages.  J Immunol. 2000;  164 3471-3475
    PubMedSuche in Google Scholar

Kumar VisvanathanM.B.B.S. Ph.D. F.R.A.C.P. 

Department of Medicine, Level 5, Block E, 246 Clayton Road

Clayton, Victoria 3168, Australia